相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SARS-CoV-2 Viral Variants-Tackling a Moving Target
John R. Mascola et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Variant-proof vaccines - invest now for the next pandemic
Dennis R. Burton et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer et al.
NATURE MEDICINE (2021)
A new lease on life for an HIV-neutralizing antibody class and vaccine target
Dennis R. Burton
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A universal coronavirus vaccine
Wayne C. Koff et al.
SCIENCE (2021)
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Yang Li et al.
CELL REPORTS (2021)
Structural basis for broad coronavirus neutralization
Maximilian M. Sauer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Ge Song et al.
NATURE COMMUNICATIONS (2021)
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
Chunyan Wang et al.
NATURE COMMUNICATIONS (2021)
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
Uri Greenbaum et al.
FRONTIERS IN IMMUNOLOGY (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
Emanuele Andreano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Meng Yuan et al.
SCIENCE (2021)
Broad betacoronavirus neutralization by a stem helix-specific human antibody
Dora Pinto et al.
SCIENCE (2021)
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
Paulina Kaplonek et al.
SCIENCE IMMUNOLOGY (2021)
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses
Jason T. Ladner et al.
CELL REPORTS MEDICINE (2021)
Viral targets for vaccines against COVID-19
Lianpan Dai et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Rational Vaccine Design in the Time of COVID-19
Dennis R. Burton et al.
CELL HOST & MICROBE (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Linlin Bao et al.
NATURE (2020)
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Eskild Petersen et al.
LANCET INFECTIOUS DISEASES (2020)
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Shuo Du et al.
CELL (2020)
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
Yang Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Anna Z. Wec et al.
SCIENCE (2020)
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan et al.
SCIENCE (2020)
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates
Gideon Meyerowitz-Katz et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
Tomer Zohar et al.
CELL (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Structure-Based Vaccine Antigen Design
Barney S. Graham et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Human Coronavirus: Host-Pathogen Interaction
To Sing Fung et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 73 (2019)
Commonality despite exceptional diversity in the baseline human antibody repertoire
Bryan Briney et al.
NATURE (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Repertoire Builder: high-throughput structural modeling of B and T cell receptors
Dimitri Schritt et al.
MOLECULAR SYSTEMS DESIGN & ENGINEERING (2019)
Improvements to the APBS biomolecular solvation software suite
Elizabeth Jurrus et al.
PROTEIN SCIENCE (2018)
Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development
Kevin Wiehe et al.
CELL HOST & MICROBE (2018)
Shaping a universally broad antibody response to influenza amidst a variable immunoglobulin landscape
Sarah F. Andrews et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Strategies for a multi-stage neutralizing antibody-based HIV vaccine
Raiees Andrabi et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region
Andrew I. Flyak et al.
NATURE MICROBIOLOGY (2018)
Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China
Ning Wang et al.
VIROLOGICA SINICA (2018)
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer
Liwei Cao et al.
NATURE COMMUNICATIONS (2018)
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen
Weston B. Struwe et al.
CELL REPORTS (2018)
Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
Rameshwar U. Kadam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus
S. J. Anthony et al.
MBIO (2017)
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise
Dennis R. Burton
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Structural basis of potent Zika-dengue virus antibody cross-neutralization
Giovanna Barba-Spaeth et al.
NATURE (2016)
SARS-like WIV1-CoV poised for human emergence
Vineet D. Menachery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
Raiees Andrabi et al.
IMMUNITY (2015)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Vineet D. Menachery et al.
NATURE MEDICINE (2015)
Broad-spectrum antivirals against viral fusion
Frederic Vigant et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
Marcella Sarzotti-Kelsoe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Xing-Yi Ge et al.
NATURE (2013)
IgBLAST: an immunoglobulin variable domain sequence analysis tool
Jian Ye et al.
NUCLEIC ACIDS RESEARCH (2013)
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Joseph Jardine et al.
SCIENCE (2013)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Inhibition of HIV-1 by Fusion Inhibitors
Dirk Eggink et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
Kailang Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
H Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations
TJ Dolinsky et al.
NUCLEIC ACIDS RESEARCH (2004)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
